T-regulatory cell therapy

· Cellenkos, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T-regulatory cell therapy, covering 2025-04-13 to 2025-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs [Phase 1]